pH-Responsive dopamine-based nanoparticles assembled via Schiff base bonds for synergistic anticancer therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• The tumor microenvironment's acidic pH presents opportunities for targeted therapies.
• Dopamine-based materials offer unique properties for biomedical applications.
• Schiff base chemistry provides dynamic linkages for responsive systems.

Purpose of the Study:

• To construct monodisperse, autofluorescent, and pH-sensitive nanoparticles from dopamine.
• To utilize these nanoparticles for monitoring and pH-responsive drug release.
• To achieve synergistic anticancer efficacy by co-loading doxorubicin and chlorin e6.

Main Methods:

• Synthesis of dopamine-based nanoparticles utilizing dynamic Schiff base bonds.
• Incorporation of autofluorescence for monitoring capabilities.
• Loading of anticancer drug doxorubicin and photosensitizer chlorin e6.
• Evaluation of pH-responsive drug release and in vitro anticancer efficacy.

Main Results:

• Monodisperse nanoparticles with inherent autofluorescence and pH-sensitivity were successfully synthesized.
• Facile monitoring of nanoparticle behavior and controlled drug release in acidic conditions were demonstrated.
• Co-delivery of doxorubicin and chlorin e6 resulted in enhanced synergistic anticancer efficacy.

Conclusions:

• The developed dopamine-based nanoparticles are promising for targeted cancer therapy.
• The dynamic Schiff base bond is a valuable tool for creating responsive nanocarriers.
• Autofluorescence and pH-sensitivity enable effective monitoring and triggered drug release in the tumor microenvironment.